Huikwang Corporation (6508) AI Stock Analysis

Huikwang Corporation

(TPEx:6508)

Select Model

Rating:52Neutral

Price Target:TWD 27.00▼(-0.92% Downside)

Action:initiatedcoverage

Date:11/10/26

The overall score of 52 reflects a company with a strong, low-risk balance sheet that is overshadowed by a deep operational downturn. The most significant factor is the severe and sustained decline in revenue and profitability, which makes the high P/E ratio difficult to justify. While the company is financially safe and cash flow remains positive, the lack of earnings momentum and neutral technical picture provide no catalyst for near-term improvement.

Positive Factors

Low leverageVery low and improving leverage gives Huikwang meaningful financial flexibility in a cyclical chemicals environment. A strong capital structure reduces solvency pressure, supports resilience during weaker demand, and preserves capacity to fund operations or strategic investments without heavy borrowing.

Negative Factors

Persistent revenue declineFour consecutive annual revenue declines point to sustained pressure on demand, market position, or business scale rather than a single weak quarter. Continued contraction can reduce operating leverage, limit reinvestment capacity, and make a durable earnings recovery more difficult.

Huikwang Corporation (6508) vs. SPDR S&P 500 ETF (SPY)

Market Cap: TWD 2.36B
Dividend Yield: 1.83%
Average Volume (3M): 61.87K
Price to Earnings (P/E): 26.7
Beta (1Y): 0.02
Revenue Growth: -14.31%
EPS Growth: 315.97%
Country: TW
Employees: 140
Sector: General
Sector Strength: 55
Industry: Chemicals

Huikwang Corporation Business Overview & Revenue Model

Company Description

Huikwang Corporation, founded in 1954 and headquartered in Tainan, Taiwan, is engaged in a broad spectrum of industrial activities. The company specializes in the full production lifecycle—from manufacturing and processing to packaging and trading—of...

Huikwang Corporation Financial Statement Overview

Summary

Financial performance is mixed. A fortress balance sheet (Score: 75) with minimal debt provides significant resilience. However, the income statement (Score: 35) shows a severe multi-year decline in revenue and profit margins. Cash flow (Score: 55) has stabilized at lower levels with good earnings quality. The overall financial health is anchored by balance sheet strength, but operational deterioration is a major concern.

Income Statement

35Negative

Balance Sheet

75Positive

Cash Flow

55Neutral

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.35B	1.42B	1.48B	1.53B	2.49B	2.09B
Gross Profit	316.37M	318.81M	314.51M	339.06M	607.82M	543.41M
EBITDA	92.94M	105.92M	167.76M	174.67M	454.13M	527.38M
Net Income	87.90M	23.02M	92.57M	90.92M	314.46M	329.08M
Balance Sheet
Total Assets	2.78B	2.81B	2.90B	2.97B	3.26B	3.18B
Cash, Cash Equivalents and Short-Term Investments	808.35M	791.38M	724.42M	675.38M	611.20M	672.98M
Total Debt	41.24M	115.45M	134.94M	275.62M	348.31M	332.93M
Total Liabilities	336.99M	412.10M	446.53M	551.62M	710.83M	730.78M
Stockholders Equity	2.44B	2.40B	2.45B	2.42B	2.55B	2.45B
Cash Flow
Free Cash Flow	176.07M	190.98M	180.36M	418.86M	119.88M	-104.01M
Operating Cash Flow	176.86M	205.37M	211.78M	438.42M	136.12M	-86.76M
Investing Cash Flow	-77.06M	-64.67M	-28.60M	-15.06M	141.14M	-61.36M
Financing Cash Flow	-157.17M	-126.90M	-144.32M	-361.53M	-247.00M	-276.28M

Huikwang Corporation Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TW:6508 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TW:1240	57Neutral	TWD 2.55B	11.61	―	5.32%	5.31%	-6.78%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TW:6508	52Neutral	TWD 2.34B	26.65	―	1.83%	-14.31%	315.97%
TW:4714	37Underperform	TWD 2.37B	-14.02	―	1.75%	74.42%	-247.01%

* General Sector Average

Performance Comparison

TW:6508 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TW:6508	Huikwang Corporation	27.25	3.71	15.77%
TW:1240	Morn Sun Feed Mill Corp.	53.70	1.77	3.40%
TW:4714	U-Best Innovative Technology Co.,Ltd	10.80	-6.12	-36.17%
TW:6936	Vetnostrum Animal Health Co., Ltd.	31.80	-1.47	-4.41%
TW:7850	Protect Animal Health Incorporation	21.50	-13.65	-38.83%
TW:7860	Teh Seng Pharmaceutical Mfg Co Ltd	77.80	5.13	7.07%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026

Huikwang Corporation AI Stock Analysis